Harnessing the unique biology of CD73 for improving endometrial cancer outcomes

被引：0
|
作者：
Bowser, Jessica L.
Lee, Hannah N.
Hirsch, Rebecca H.
Zhang, Xingyuan
Broaddus, Russell R.
Kurnit, Katherine C.
Crumley, Suzanne M.
Premsankar, Sunthoshini
Rabjohns, Emily M.
Chiou, Lilly F.
Vaziri, Cyrus
机构：
来源：
CLINICAL CANCER RESEARCH | 2024年 / 30卷 / 05期
关键词：
D O I：
10.1158/1557-3265.ENDO24-IA022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA022
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Harnessing the unique immune biology of cytomegalovirus for cancer immunotherapy
    Iyer, L. Ravi F.
    Verweij, Marieke C.
    Nair, Sujit
    Morrow, David
    Mansouri, Mandana
    Beechwood, Teresa
    Meyer, Christine
    Chakravarty, Dimple
    Uebelhoer, Luke
    Uebelhoer, Luke
    Ventura, Abigail
    Lauron, Elvin J.
    Selseth, Andrea
    Axthelm, Michael
    Lind, Evan F.
    Saultz, Jennifer
    Douglas, Janet
    Korman, Alan
    Bhardwaj, Nina
    Tewari, Ashutosh K.
    Hansen, Scott G.
    Malouli, Daniel
    Picker, Louis J.
    Fruh, Klaus
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [22] A differentiated CD73 blocking antibody with a unique intra-dimer binding mechanism for cancer immunotherapy.
    Wang, Zhengyi
    Cao, Wei
    Zhang, Yanni
    Xu, Cong
    Meng, Yuan
    Guo, Taylor B.
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention
    Singh, Kanchan
    Chandra, Vidhi
    Ballew, Lincoln
    Mills, Tingting
    Faraoni, Erika Y.
    Clark, Trent
    Vornik, Lana A.
    Savage, Michelle I.
    Eltzschig, Holger K.
    Mohammed, Altaf
    Sei, Shizuko
    Brown, Powel H.
    McAllister, Florencia
    Bailey-Lundberg, Jennifer
    CANCER RESEARCH, 2022, 82 (12)
  • [24] Identification and Expression Analysis of CD73 Inhibitors in Cervical Cancer
    Iqbal, Jamshed
    Basharat, Ayesha
    Bano, Sehrish
    Abid, Syed Mobasher Ali
    Pelletier, Julie
    Sevigny, Jean
    MEDICINAL CHEMISTRY, 2021, 17 (08) : 866 - 874
  • [25] CD73 Expression Is an Independent Prognostic Factor in Prostate Cancer
    Leclerc, Bruno G.
    Charlebois, Roxanne
    Chouinard, Guillaume
    Allard, Bertrand
    Pommey, Sandra
    Saad, Fred
    Stagg, John
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 158 - 166
  • [26] Expression of CD73 is associated with the molecular subtypes of breast cancer
    Jeong, Y. J.
    Choi, H. R.
    Oh, H. K.
    Park, S. H.
    Bong, J. G.
    BREAST, 2017, 32 : S95 - S96
  • [27] Prognostic impact of CD73 expression in epithelial ovarian cancer
    Park, Junsik
    Kim, Nari
    Lee, Yong Jae
    Kim, Sunghoon
    Kim, Sang Wun
    Lee, Jung-Yun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A91 - A91
  • [28] Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer
    Sabnis, Ram W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (06): : 775 - 776
  • [29] Significance of CD73 expression in invasive breast cancer stroma
    Aoki, Mikio
    Koga, Kaori
    Nabeshima, Kazuki
    Hamasaki, Makoto
    CANCER SCIENCE, 2023, 114 : 2157 - 2157
  • [30] Preclinical testing of CD73 inhibitors for pancreatic cancer immunoprevention
    Ballew, Lincoln
    Singh, Kanchan
    Chandra, Vidhi
    Mills, Tingting
    Faraoni, Erika Y.
    Mota, Victoria
    Clark, Trent
    Vornik, Lana
    Savage, Michelle I.
    Sei, Shizuko
    Mohammed, Altaf
    Eltzschig, Holger K.
    Brown, Powel H.
    McAllister, Florencia
    Bailey-Lundberg, Jennifer M.
    CANCER PREVENTION RESEARCH, 2022, 15 (12)
12345